Once the bioactive component has be

Once the bioactive component has been obtained in pure
form, either as a novel structure or as a known compound
exhibiting previously unreported activity, it must then be
tested in a series of biological assays to determine its efficacy,
potency, toxicity, and pharmacokinetics. These assays will
help to determine the priority of the compound’s spectrum
of activity within the portfolio of compounds that a group
may be assessing for advanced development as either drug
candidates or leads thereto